Interesting EP Cases Catheter ablation to treat congestive heart failure (CHF)

Size: px
Start display at page:

Download "Interesting EP Cases Catheter ablation to treat congestive heart failure (CHF)"

Transcription

1 Interesting EP Cases Catheter ablation to treat congestive heart failure (CHF) Yiming WU, MD, PhD. Alaska heart and vascular institute

2 19 yo man transferred for out side hospital cardiac arrest d/t ventricular fibrillation s/p cardioversion x3. + for meth, EF 45% and recovered to 60% in 3 days.

3 Prevalence of Early Repolarization in patients with idiopathic VF and controls Sudden Cardiac Arrest Associated with Early Repolarization N Engl J Med 2008; 358: % 50% 40% 30% 20% 10% 0% Idiopathic VF Controls P = Actuarial Curves for Case Subjects with VT, According to the Presence or Absence of Early Repolarization(Mean follow up 61 +/- 50 months); risk for recurrent VF.

4 Case reports, case control studies, and population studies established a link between the presence of ER and an increased risk for arrhythmic death / idiopathic ventricular fibrillation (VF) Estimated risk of developing idiopathic VF in an individual younger than 45 years is 3 in 100,000; The risk increased to 10 in 100,000 when J waves present. Association of ER with arrhythmic risk is typically at rest or during sleep and not during physical activity when J-point elevation is typically markedly reduced or eliminated. Among survivors of SCD due to idiopathic VF, the reported rate of recurrent VF ranges between % at 2-4 years; 41% at follow up of 5 years. Because ER syndrome patients have no structural heart disease, they have an excellent prognosis for long-term survival if VF is treated

5 60 yo woman transferred for, severe MR, atrial flutter with RVR, v fib post cardioversion.

6

7 Synchronized cardioversion: Timing of shock to avoid peak of T wave. Prevents VF caused by delivering shock during venerable period.

8 Location, location and location. Timing, timing and timing. The first ECG record of VF after a blow to the chest of a hare using a hammer. Maron BJ and Estes III NAM, NEJM 362:917, 2010.

9 Ms. JLF, 64 yo, female, referred for possible ICD implantation on 4/1/2014. Paroxysmal atrial fibrillation since Chronic atrial fibrillation at least since 11/2013. Failed cardioversion and on rate control. All EKGs show that the ventricular rate between bpm indicating well rate controlled. On optimal CHF medication. LVEF: 55-60% (2011), 45% (11/2013), 35% (2/2014). Coronary angiogram (11/2013): non-obstructive CAD.

10 Diagnosis: non-ischemic cardiomyopathy (NICM). Next: 1. Can exclude the NICM is due to atrial fibrillation. 2. ICD implantation for primary prevention. A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators.

11 How to test the hypothesis: atrial fibrillation causes NICM? Rhythm control: antiarrhythmic drug or ablation. Amiodarone was loaded and cardioverted into sinus rhythm. LVEF: 45% (5/2014), 51-55% (3/2015), 56-60% (7/2015), 56-60% (10/2016)

12

13

14 Worried about side effects of Amioraone. Underwent catheter ablation 7/9/ /28/2017 evaluated in clinic, still in sinus rhythm

15

16 Mechanisms for AF to induce HF Irregular rhythm decreases cardiac output. Persistent tachycardia may lead to tachycardia mediated cardiomyopathy. Loss of atrial systole required for optimal ventricular filling. Activation of neuro-humoral vasoconstrictors.

17 58 pts with AF+CHF, LVEF 45%, F/U a mean (±SD) of 12±7 months post ablation. 78% still in sinus rhythm Hsu L, et al, Catheter Ablation for Atrial Fibrillation in Congestive Heart Failure. N Engl J Med 2004; 351:

18 Atrial fibrillation and CHF (AF-CHF trial) rate control vs. rhythm control A multicenter, randomized trial comparing the maintenance of sinus rhythm (rhythm control) with control of the ventricular rate (rate control) in patients with a left ventricular ejection fraction of 35% or less, symptoms of congestive heart failure, and a history of atrial fibrillation. The primary outcome was the time to death from cardiovascular causes Roy D, eat al. Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure. N Engl J Med 2008; 358:

19 Roy D, eat al. Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure. N Engl J Med 2008; 358:

20 Benefits: rate control = rhythm control. Amiodarone harms the patients and reduces the benefits of rhythm control. Famous CAST Echt DS, et al. Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991; 324:781-8

21 203 CHF + Persistent AF pts with device (ICD), LVEF 0.40, NYHA II-III. AATAC-AF: Secondary Endpoints Cardiovascular Hospitalization All-Cause Mortality Ablation Amiodarone P Value 32 (31%) 58 (57%) < (8%) 18 (18%) Biase L, et al. Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device Results From the AATAC Multicenter Randomized Trial. Circulation. 2016;133:

22 Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction: The CAMERA-MRI Study This multicenter, randomized patients with persistent AF and idiopathic cardiomyopathy (LVEF 45%). Pts underwent CMR to assess LVEF and late gadolinium enhancement (ventricular fibrosis) then randomization to either CA or ongoing MRC. The primary endpoint was change in LVEF on repeat CMR at 6 months. (33 pts in each group)

23 CONCLUSIONS: AF is an underappreciated reversible cause of LV systolic dysfunction (LVSD) in this population despite adequate rate control. The restoration of sinus rhythm with catheter ablation (CA) results in significant improvements in ventricular function, particularly in the absence of ventricular fibrosis on cardiac MRI. This outcome challenges the current treatment paradigm that rate control is the appropriate strategy in patients with AF and LVSD.

24 Catheter Ablation versus Standard conventional Treatment in patients with LEft ventricular dysfunction and Atrial Fibrillation. (CASTLE-AF trial) 397 pts with symptomatic paroxysmal or persistent AFib and a left ventricular ejection fraction (LVEF) of 35 %, with ICD or CRTD, for radiofrequency catheter ablation or conventional drug treatment. In SR at 60 m: Ablation: 63.1% MRC: 21.7%

25

26

27 Ablation MRC Death 13.4% 25.0% CHF admission 20.7% 35.9% CV death 11.2% 22.3% LVEF change 8.0% 0.2%

28

29 By the year 2030, there will be 12 million Americans with AF, and over 8 million with HF individuals ( ) with new AF, (75±12 yo, 48% F) more than one third (37%) had HF individuals with new HF (79±11 yo, 53% F), more than half (57%) had AF. Prevalent AF was more strongly associated with incident HFpEF vs HFrEF. Prevalent HF was associated with incident AF. AF precedes and follows HF with both preserved and reduced ejection fraction. The presence of both AF and HF portended greater mortality risk. Santhanakrishnan, J. et al. Circulation. 2016; 133:

30 Atrial fibrillation can cause CHF even with well ventricular rate controlled. Because irregularity can reduce the myocardial contractility, like PVCs and PACs. Catheter ablation is superior to medication.

31

32 78 yo male from Valdez with CAD, MI s/p PCI. Echo (TTE) in 9/2017: LVEF 40-45%, No MR, moderate AS (AVA 1.0 cm2, normal cm2). EKG: 11/2016: SR. 9/2017: A fib Worsening CHF on optimal medical treatment. TEE (2/9/2018): LVEF 15-20%, moderate to severe MR, moderate to severe AS. Had atrial fibrillation ablation yesterday.

33 Dr.Wu~ I feel like my life has been handed back to me as I've been out shooting some photography and walking the bike trails. And I've been arrhythmia free for 20 days now!! I've had a PVC or two but they are random. I thank you with all of my happy heart! I've included a couple of my photos :)

34

35 43 yo, female, fatigue, otherwise asymptomatic. LVEF 35% Sinus rhythm and PVCs?

36 RSPV CS His Bondle

37 RL PA

38

39 Post ablation Before ablation

40 Repeated echo 5 wks later: LVEF 62%. Lisinopril and metoprolol were discontinued. Echo 5 months later: LVEF 60%.

41

42 75 yo female, tired and dizzy, pulse rate ~ 40 bpm. PCP sent her for evaluation of pacemaker implantation

43

44 Dog model of bigeminal PVC Jose F. Huizar et al. Circ Arrhythm Electrophysiol. 2011;4:

45

46 Activation and pacing mapping indicated RVOT PVC. The PVC was successfully ablated.

47 Why not anti-arrhythmic medication Famous CAST Echt DS, et al. Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991; 324:781-8

48 28 yo, F, palpitation for 7 years. PVCs refractory to beta blockers and mexilletine. Echo: LVEF 38%. 48 Holter reveals 32.4% PVCs

49

50 Does she need a PVC ablation: symptom? CHF? Cosmetic?

51 PVC ablation, RVOT PVC

52 Echo (5 months later): EF 67%. 48 holter (5 months later): 1% PVCs.

53 6-month survival of patients post MI by premature ventricular contractions (PVCs) per hour J Lifestyle Med ; 3(1):

54

55 Ventricular Ectopy as a Predictor of Heart Failure and Death. Objectives The goal of this study was to determine whether PVC frequency ascertained using a 24-h Holter monitor is a predictor of LVEF decline, incident CHF, and death in a population-based cohort. Quartiles 1 through 4 represent PVC burdens of 0% to 0.002%, 0.002% to 0.011%, 0.011% to 0.123%, and 0.123% to 17.7%, respectively J Am Coll Cardiol ; 66:

56 Conclusions In a population-based sample, a higher frequency of PVCs was associated with LVEF decline, increased incident CHF, and increased mortality. The population-level risk for incident CHF attributed to PVCs was 8.1% (95% CI: 1.2 to14.9%). Given the capacity to prevent PVCs through medical or ablation therapy, PVCs may represent a modifiable risk factor for CHF and death. J Am Coll Cardiol ; 66:

57 Dogs, couple interval 240 ms, RVA PVCs Heart Rhythm. 2016; 13:

58 PVC burden of >24% had a sensitivity and specificity of 79% and 78%,

59 J Am Coll Cardiol 2013;62: )

60 Risk factors for PVCs induced cardiomyopathy (CMP) 1) PVC burden: Baman et al.: 24%. Munoz F, et al. (J Cardiovasc Electrophysiol. 2011;22:791 8): PVCs originating from the RV 10%, PVCs originating from the LV 20%. Can H, et al, ( J. Cardiovasc. Electrophysiol. 2011;22:663 8): 16%. Ban Ji-Eun et al, (Europace. 2013;15:735 41): 26%. Many others: 10% So far, there are no clear-cut points that mark the frequency at which CMP is unavoidable. 2) PVC origin, morphology and duration: RV origin. Wider QRS. Shorter couple interval 3) Underlying heart diseases.

61 4 centers, 80 pts, 27 pts with SHD. Successful PVC ablation in 53 pts. Gray bar = no SHD, black bar= SHD. Independently of the presence of SHD, improvement in heart failure parameters was related to baseline PVC burden and persistence of ablation success. J Am Coll Cardiol 2013;62: )

62 Catheter ablation Conventional treatment (ACEI, BB) Latchamsetty RY, Morady Miki, Kim Fred, et al. Multicenter outcomes for catheter ablation of idiopathic premature ventricular complexes. JACC: Clin Electrophysiol. 2015;1: Bogun F, Crawford T, Reich S, et al. Radiofrequency ablation of frequent, idiopathic premature ventricular complexes: Comparison with a control group without intervention. Heart Rhythm. 2007;4:863 7.

63 If cardiomyopathy causes PVCs, then successful ablation of PVC may slightly increase or does not change LVEF. Or the LVEF even continuously reduces but hopefully slower.

64 Early Elimination of Premature Ventricular Contractions in Heart Failure (EVAC-HF) Inclusion Criteria: Patients with reduced ejection fraction (EF 45%) demonstrated by transthoracic echocardiogram and deemed to be non-ischemic by nuclear stress test or cardiac catheterization. Patients with >20% PVCs on 24 hour holter-recording Patient is 18 years of age or older Optimized medical therapy on stable therapy for minimum 3 months with no changes in beta-blocker, ACE-I/ARB, digoxin doses (varying diuretic doses permitted).

65

66 30 yo man, in ER, normal heart per echo avr avl Outflow tract VT: Structurally normal Normal LVEF RVOT or LVOT EKG: LBBB, + QRS in II/III/aVF, -QRS in avr/avl Not life-threatening CAMP dependent VT Sensitive to CCB/BB NO ICD Ablation has good outcome II/III/aVF

67 Except rapid pacing induced CM, all the other arrhythmias on the list can be treated by catheter ablation. J Am Coll Cardiol. 2015; 66(15):

68

69

PVCs: Do they cause Cardiomyopathy? Raed Abu Sham a, M.D.

PVCs: Do they cause Cardiomyopathy? Raed Abu Sham a, M.D. PVCs: Do they cause Cardiomyopathy? Raed Abu Sham a, M.D. Cardiologist and Electrophysiologist No conflict of interest related to this presentation Objectives 1. PVCs are benign. What is the Evidence?

More information

Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh

Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh Arrhythmias and Heart Failure Ventricular Supraventricular VT/VF Primary prevention

More information

علم االنسان ما لم يعلم

علم االنسان ما لم يعلم In the name of Allah, the Beneficiate, the Merciful ق ال هللا تعالي: 5 الدى علم بالق لم 4 علم االنسان ما لم يعلم سورة العلق It is He (Allah), Who has taught by the pen He has taught man which he did not

More information

Synopsis of Management on Ventricular arrhythmias. M. Soni MD Interventional Cardiologist

Synopsis of Management on Ventricular arrhythmias. M. Soni MD Interventional Cardiologist Synopsis of Management on Ventricular arrhythmias M. Soni MD Interventional Cardiologist No financial disclosure Premature Ventricular Contraction (PVC) Ventricular Bigeminy Ventricular Trigeminy Multifocal

More information

Atrial Fibrillation and Heart Failure: Rate vs. Rhythm Control Time for Re-evaluation

Atrial Fibrillation and Heart Failure: Rate vs. Rhythm Control Time for Re-evaluation Atrial Fibrillation and Heart Failure: Rate vs. Rhythm Control Time for Re-evaluation ANIL K. BHANDARI, M.D, Director, Electrophysiology and EPS Fellowship Program Good Samaritan Hospital/ Harbor UCLA

More information

Atrial Fibrillation Ablation in Patients with Heart Failure

Atrial Fibrillation Ablation in Patients with Heart Failure Atrial Fibrillation Ablation in Patients with Heart Failure Eleftherios M. Kallergis, MD, PhD, FESC Cardiology Department, Heraklion University Hospital Since auricular fibrillation so often complicates

More information

Tachycardia-induced heart failure - Does it exist?

Tachycardia-induced heart failure - Does it exist? Tachycardia-induced heart failure - Does it exist? PD Dr Etienne Delacrétaz Clinique Cecil et Hôpital de Fribourg SSC Cardiology meeting 2015 Zürich Rapid atrial fibrillation is a common cause of heart

More information

Role of Ablation of AF and PVCs in the Management of Heart Failure

Role of Ablation of AF and PVCs in the Management of Heart Failure Role of Ablation of AF and PVCs in the Management of Heart Failure Cara Pellegrini, MD, FHRS Acting Chief, Cardiology, SF VA Associate Professor of Medicine, UCSF Disclosures I have nothing to disclose

More information

Polypharmacy - arrhythmic risks in patients with heart failure

Polypharmacy - arrhythmic risks in patients with heart failure Influencing sudden cardiac death by pharmacotherapy Polypharmacy - arrhythmic risks in patients with heart failure Professor Dan Atar Head, Dept. of Cardiology Oslo University Hospital Ullevål Norway 27.8.2012

More information

Treatment of Atrial Fibrillation in Heart Failure

Treatment of Atrial Fibrillation in Heart Failure Stockholm, September 1st 2010 Treatment of Atrial Fibrillation in Heart Failure Rhythm control: Which drugs? Stefan H. Hohnloser J.W. Goethe University Frankfurt, Germany Presenter disclosure information:

More information

Ablation Update and Case Studies. Lawrence Nair, MD, FACC Director of Electrophysiology Presbyterian Heart Group

Ablation Update and Case Studies. Lawrence Nair, MD, FACC Director of Electrophysiology Presbyterian Heart Group Ablation Update and Case Studies Lawrence Nair, MD, FACC Director of Electrophysiology Presbyterian Heart Group Disclosures No financial relationships to disclose Objectives At the conclusion of this activity,

More information

Atrial Fibrillation and the NOAC s. John Raymond MS, PA-C, MHP February 10, 2018

Atrial Fibrillation and the NOAC s. John Raymond MS, PA-C, MHP February 10, 2018 Atrial Fibrillation and the NOAC s John Raymond MS, PA-C, MHP February 10, 2018 Pathogenesis EPIDEMIOLOGY Arrhythmia-related hospitalisations in the US Ventricular fibrillation 2% Atrial fibrillation 34%

More information

Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know

Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know Steven J. Kalbfleisch, M.D. Medical Director Electrophysiology Laboratory Ross Heart Hospital Wexner Medical Center Sudden

More information

Atrial Fibrillation Ablation in Patients with Heart Failure

Atrial Fibrillation Ablation in Patients with Heart Failure Atrial Fibrillation Ablation in Patients with Heart Failure Eleftherios M. Kallergis, MD, PhD, FESC Cardiology Department, Heraklion University Hospital Since auricular fibrillation so often complicates

More information

Ventricular Tachycardia Ablation. Saverio Iacopino, MD, FACC, FESC

Ventricular Tachycardia Ablation. Saverio Iacopino, MD, FACC, FESC Ventricular Tachycardia Ablation Saverio Iacopino, MD, FACC, FESC ü Ventricular arrhythmias, both symptomatic and asymptomatic, are common, but syncope and SCD are infrequent initial manifestations of

More information

Atrial Fibrillation: Rate vs. Rhythm. Michael Curley, MD Cardiac Electrophysiology

Atrial Fibrillation: Rate vs. Rhythm. Michael Curley, MD Cardiac Electrophysiology Atrial Fibrillation: Rate vs. Rhythm Michael Curley, MD Cardiac Electrophysiology I have no relevant financial disclosures pertaining to this topic. A Fib Epidemiology #1 Most common heart rhythm disturbance

More information

Do All Patients With An ICD Indication Need A BiV Pacing Device?

Do All Patients With An ICD Indication Need A BiV Pacing Device? Do All Patients With An ICD Indication Need A BiV Pacing Device? Muhammad A. Hammouda, MD Electrophysiology Laboratory Department of Critical Care Medicine Cairo University Etiology and Pathophysiology

More information

Devices and Other Non- Pharmacologic Therapy in CHF. Angel R. Leon, MD FACC Division of Cardiology Emory University School of Medicine

Devices and Other Non- Pharmacologic Therapy in CHF. Angel R. Leon, MD FACC Division of Cardiology Emory University School of Medicine Devices and Other Non- Pharmacologic Therapy in CHF Angel R. Leon, MD FACC Division of Cardiology Emory University School of Medicine Disclosure None University of Miami vs. OSU Renegade Miami football

More information

All in the Past? Win K. Shen, MD Mayo Clinic Arizona Controversies and Advances in CV Diseases Cedars-Sinai Heart Institute, MFMER

All in the Past? Win K. Shen, MD Mayo Clinic Arizona Controversies and Advances in CV Diseases Cedars-Sinai Heart Institute, MFMER ICD for NICM All in the Past? Win K. Shen, MD Mayo Clinic Arizona Controversies and Advances in CV Diseases Cedars-Sinai Heart Institute, 2017 2017 MFMER 3686275-1 DISCLOSURE Relevant Financial Relationship(s)

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure (review

More information

What s new in my specialty?

What s new in my specialty? What s new in my specialty? Jon Melman, MD Heart Rhythm Specialists McKay-Dee Hospital some would say some would say my specialty 1 some would say my specialty First pacemaker 1958 some would say my specialty

More information

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Colette Seifer MB(Hons) FRCP(UK) Associate Professor, University of Manitoba, Cardiologist, Cardiac Sciences Program, St Boniface Hospital

More information

Dos and Don t in Cardiac Arrhythmia. Case 1 -ECG. Case 1. Management. Emergency Admissions. Reduction of TE risk -CHADS 2 score. Hospital Admissions

Dos and Don t in Cardiac Arrhythmia. Case 1 -ECG. Case 1. Management. Emergency Admissions. Reduction of TE risk -CHADS 2 score. Hospital Admissions Emergency Admissions Dos and Don t in Cardiac Arrhythmia Tom Wong, MD, FESC Consultant Cardiologist, Honorary Senior Lecturer Royal Brompton & Harefield Hospitals National Heart and Lung Institute, Imperial

More information

Ruolo della ablazione della fibrillazione atriale nello scompenso cardiaco

Ruolo della ablazione della fibrillazione atriale nello scompenso cardiaco Ruolo della ablazione della fibrillazione atriale nello scompenso cardiaco Matteo Anselmino Division of Cardiology Città della Salute e della Scienza Hospital University of Turin, Italy Disclosure: Honoraria

More information

State-of-the-Art Management of Chronic Systolic Heart Failure

State-of-the-Art Management of Chronic Systolic Heart Failure State-of-the-Art Management of Chronic Systolic Heart Failure Michael McCulloch, MD 17 th Annual Cardiovascular Update Intermountain Medical Center December 16, 2017 Disclosures: I have no financial disclosures

More information

Recurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm

Recurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm Recurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm Guy Amit, MD, MPH Soroka University Medical Center Ben-Gurion University of the Negev Beer-Sheva, Israel Disclosures Consultant:

More information

Rate vs. Rhythm Control in Atrial Fibrillation

Rate vs. Rhythm Control in Atrial Fibrillation Rate vs. Rhythm Control in Atrial Fibrillation Recent Perspectives Saeed Oraii MD Electrophysiologist Interventional Electrophysiologist Tehran Arrhythmia Clinic Delirium Cordis First described by Sir

More information

AF :RHYTHM CONTROL BY DR-MOHAMMED SALAH ASSISSTANT LECTURER CARDIOLOGY DEPARTMENT

AF :RHYTHM CONTROL BY DR-MOHAMMED SALAH ASSISSTANT LECTURER CARDIOLOGY DEPARTMENT AF :RHYTHM CONTROL BY DR-MOHAMMED SALAH ASSISSTANT LECTURER CARDIOLOGY DEPARTMENT 5-2014 Atrial Fibrillation therapeutic Approach Rhythm Control Thromboembolism Prevention: Recommendations Direct-Current

More information

Tehran Arrhythmia Center

Tehran Arrhythmia Center Tehran Arrhythmia Center The Worst Scenario A 4 year old kid High heart rates first noted by parents at 20 months of age. Family physician detected rates as high as 220 bpm at that age. He was visited,

More information

When to ablate patients with premature ventricular complexes?

When to ablate patients with premature ventricular complexes? When to ablate patients with premature ventricular complexes? Nikolaos Fragakis Assistant Professor, FESC 3rd University Cardiology Department Hippokration Hospital, Thessaloniki 58 year-old female Case

More information

Are Drugs Better? Dr Mauro Lencioni. Drugs or ablation as first line treatment for AF? Consultant Cardiologist & Electrophysiologist

Are Drugs Better? Dr Mauro Lencioni. Drugs or ablation as first line treatment for AF? Consultant Cardiologist & Electrophysiologist Are Drugs Better? Drugs or ablation as first line treatment for AF? Dr Mauro Lencioni Consultant Cardiologist & Electrophysiologist The Philosophical Issue What do we mean by Better? Outcome measures Measurement

More information

Atrial Fibrillation: Catheter Ablation with New Technologies, Improving Quality of Life and Outcomes in Various Disease States

Atrial Fibrillation: Catheter Ablation with New Technologies, Improving Quality of Life and Outcomes in Various Disease States Atrial Fibrillation: Catheter Ablation with New Technologies, Improving Quality of Life and Outcomes in Various Disease States Srinivas R. Dukkipati, MD Co-Director, Cardiac Arrhythmia Service The Mount

More information

Ventricular tachycardia Ventricular fibrillation and ICD

Ventricular tachycardia Ventricular fibrillation and ICD EKG Conference Ventricular tachycardia Ventricular fibrillation and ICD Samsung Medical Center CCU D.I. Hur Ji Won 2006.05.20 Ventricular tachyarrhythmia ventricular tachycardia ventricular fibrillation

More information

ΚΑΤΑΛΥΣΗ ΚΟΛΠΙΚΗΣ ΜΑΡΜΑΡΥΓΗΣ. ΥΠΕΡ. Michalis Efremidis MD Second Department of Cardiology Evangelismos General Hospital

ΚΑΤΑΛΥΣΗ ΚΟΛΠΙΚΗΣ ΜΑΡΜΑΡΥΓΗΣ. ΥΠΕΡ. Michalis Efremidis MD Second Department of Cardiology Evangelismos General Hospital ΚΑΤΑΛΥΣΗ ΚΟΛΠΙΚΗΣ ΜΑΡΜΑΡΥΓΗΣ. ΥΠΕΡ. Michalis Efremidis MD Second Department of Cardiology Evangelismos General Hospital Rate control versus Rhythm control for Atrial Fibrillation AFFIRM N Engl J Med 2002;347:1825-33

More information

Rhythm Control: Is There a Role for the PCP? Blake Norris, MD, FACC BHHI Primary Care Symposium February 28, 2014

Rhythm Control: Is There a Role for the PCP? Blake Norris, MD, FACC BHHI Primary Care Symposium February 28, 2014 Rhythm Control: Is There a Role for the PCP? Blake Norris, MD, FACC BHHI Primary Care Symposium February 28, 2014 Financial disclosures Consultant Medtronic 3 reasons to evaluate and treat arrhythmias

More information

Fibrillazione atriale e scompenso: come interrompere il circolo vizioso.

Fibrillazione atriale e scompenso: come interrompere il circolo vizioso. Alessandria, September 23 th 2017 Fibrillazione atriale e scompenso: come interrompere il circolo vizioso. Professor Fiorenzo Gaita Chief of the Cardiovascular Department Città della Salute e della Scienza

More information

ECTOPIC BEATS: HOW MANY COUNT?

ECTOPIC BEATS: HOW MANY COUNT? ECTOPIC BEATS: HOW MANY COUNT? Rupert FG Simpson, 1 Jessica Langtree, 2 *Andrew RJ Mitchell 2 1. King s College Hospital, London, UK 2. Jersey General Hospital, Jersey, UK *Correspondence to mail@jerseycardiologist.com

More information

Medicine. Dynamic Changes of QRS Morphology of Premature Ventricular Contractions During Ablation in the Right Ventricular Outflow Tract

Medicine. Dynamic Changes of QRS Morphology of Premature Ventricular Contractions During Ablation in the Right Ventricular Outflow Tract Medicine CLINICAL CASE REPORT Dynamic Changes of QRS Morphology of Premature Ventricular Contractions During Ablation in the Right Ventricular Outflow Tract A Case Report Li Yue-Chun, MD, Lin Jia-Feng,

More information

Rate and Rhythm Control of Atrial Fibrillation

Rate and Rhythm Control of Atrial Fibrillation Rate and Rhythm Control of Atrial Fibrillation April 21, 2017 춘계심혈관통합학술대회 Jaemin Shim, MD, PhD Arrhythmia Center Korea University Anam Hospital Treatment of AF Goal Reducing symptoms Preventing complication

More information

Understanding Atrial Fibrillation Management. Roy Lin, MD

Understanding Atrial Fibrillation Management. Roy Lin, MD Understanding Atrial Fibrillation Management Roy Lin, MD Disclosure None Definition of atrial fibrillation Atrial fibrillation is a supraventricular tachyarrhythmia characterized by uncoordinated atrial

More information

Antiarrhythmic Drugs and Ablation in Patients with ICD and Shocks

Antiarrhythmic Drugs and Ablation in Patients with ICD and Shocks Antiarrhythmic Drugs and Ablation in Patients with ICD and Shocks Alireza Ghorbani Sharif, MD Interventional Electrophysiologist Tehran Arrhythmia Clinic January 2016 Recurrent ICD shocks are associated

More information

Atrial Fibrillation Ablation Recent Clinical Trials That Changed (or not) My Practice

Atrial Fibrillation Ablation Recent Clinical Trials That Changed (or not) My Practice Atrial Fibrillation Ablation Recent Clinical Trials That Changed (or not) My Practice Walid Saliba, MD, FHRS Director, Atrial Fibrillation Center Director EP laboratory Heart and Vascular Institute Cleveland

More information

Controversies in Atrial Fibrillation and HF

Controversies in Atrial Fibrillation and HF Controversies in Atrial Fibrillation and HF Dr.Yahya Al Hebaishi Cardiac electrophysiology division, PSCC, Riyadh Atrial Fibrillation: Rate or Rhythm? HF and AF: the twin epidemic of cardiovascular disease.

More information

NAAMA s 24 th International Medical Convention Medicine in the Next Decade: Challenges and Opportunities Beirut, Lebanon June 26 July 2, 2010

NAAMA s 24 th International Medical Convention Medicine in the Next Decade: Challenges and Opportunities Beirut, Lebanon June 26 July 2, 2010 NAAMA s 24 th International Medical Convention Medicine in the Next Decade: Challenges and Opportunities Beirut, Lebanon June 26 July 2, 2010 I have a financial interest/arrangement or affiliation with

More information

SUDDEN CARDIAC DEATH(SCD): Definition

SUDDEN CARDIAC DEATH(SCD): Definition SUDDEN CARDIAC DEATH EPIDEMIOLOGY, PATHOPHYSIOLOGY, PREVENTION & THERAPY Hasan Garan, M.D. Columbia University Medical Center SUDDEN CARDIAC DEATH(SCD): Definition DEATH DUE TO A CARDIAC CAUSE IN A CLINICALLY

More information

How atrial fibrillation should be treated in the heart failure patient?

How atrial fibrillation should be treated in the heart failure patient? Advances in Cardiac Arrhhythmias and Great Innovations in Cardiology Torino, 13/15 Ottobre 2016 How atrial fibrillation should be treated in the heart failure patient? Matteo Anselmino Dipartimento Scienze

More information

SUDDEN CARDIAC DEATH(SCD): Definition

SUDDEN CARDIAC DEATH(SCD): Definition SUDDEN CARDIAC DEATH EPIDEMIOLOGY, PATHOPHYSIOLOGY, PREVENTION & THERAPY Hasan Garan, M.D. Columbia University Medical Center SUDDEN CARDIAC DEATH(SCD): Definition DEATH DUE TO A CARDIAC CAUSE IN A CLINICALLY

More information

The pill-in-the-pocket strategy for paroxysmal atrial fibrillation

The pill-in-the-pocket strategy for paroxysmal atrial fibrillation The pill-in-the-pocket strategy for paroxysmal atrial fibrillation KONSTANTINOS P. LETSAS, MD, FEHRA LABORATORY OF CARDIAC ELECTROPHYSIOLOGY EVANGELISMOS GENERAL HOSPITAL OF ATHENS ARRHYTHMIAS UPDATE,

More information

Congestive Heart Failure or Heart Failure

Congestive Heart Failure or Heart Failure Congestive Heart Failure or Heart Failure Dr Hitesh Patel Ascot Cardiology Group Heart Failure Workshop April, 2014 Question One What is the difference between congestive heart failure and heart failure?

More information

3/23/2018. Complications of VAD Therapy: Arrhythmias. Disclosures. Agenda. I have no relevant disclosures

3/23/2018. Complications of VAD Therapy: Arrhythmias. Disclosures. Agenda. I have no relevant disclosures March 23, 2018 Complications of VAD Therapy: Arrhythmias Sandeep M. Jani, MD, MPH Associate Directory of Advanced Heart Failure and Population Health MedStar Heart and Vascular Institute - Baltimore Sandeep

More information

Interventional solutions for atrial fibrillation in patients with heart failure

Interventional solutions for atrial fibrillation in patients with heart failure Interventional solutions for atrial fibrillation in patients with heart failure Advances in Cardiovascular Arrhythmias Great Innovations in Cardiology Matteo Anselmino, MD PhD Division of Cardiology Department

More information

Dysrhythmias 11/7/2017. Disclosures. 3 reasons to evaluate and treat dysrhythmias. None. Eliminate symptoms and improve hemodynamics

Dysrhythmias 11/7/2017. Disclosures. 3 reasons to evaluate and treat dysrhythmias. None. Eliminate symptoms and improve hemodynamics Dysrhythmias CYDNEY STEWART MD, FACC NOVEMBER 3, 2017 Disclosures None 3 reasons to evaluate and treat dysrhythmias Eliminate symptoms and improve hemodynamics Prevent imminent death/hemodynamic compromise

More information

Scompenso cardiaco e F A : ruolo della ablazione transcatetere. Prof. Fiorenzo Gaita

Scompenso cardiaco e F A : ruolo della ablazione transcatetere. Prof. Fiorenzo Gaita Scompenso cardiaco e F A : ruolo della ablazione transcatetere Prof. Fiorenzo Gaita Patients with atrial fibrillation (%) Prevalence of AF in HF Trials 60 50 30% NYHA III-IV NYHA IV 40 NYHA II-III 30 20

More information

Cardiac Arrhythmias. Cathy Percival, RN, FALU, FLMI VP, Medical Director AIG Life and Retirement Company

Cardiac Arrhythmias. Cathy Percival, RN, FALU, FLMI VP, Medical Director AIG Life and Retirement Company Cardiac Arrhythmias Cathy Percival, RN, FALU, FLMI VP, Medical Director AIG Life and Retirement Company The Cardiovascular System Three primary functions Transport of oxygen, nutrients, and hormones to

More information

» A new drug s trial

» A new drug s trial » A new drug s trial A placebo-controlled, double-blind, parallel arm Trial to assess the efficacy of dronedarone 400 mg bid for the prevention of cardiovascular Hospitalization or death from any cause

More information

ESC Stockholm Arrhythmias & pacing

ESC Stockholm Arrhythmias & pacing ESC Stockholm 2010 Take Home Messages for Practitioners Arrhythmias & pacing Prof. Panos E. Vardas Professor of Cardiology Heraklion University Hospital Crete, Greece Disclosures Small teaching fees from

More information

Who Gets Atrial Fibrilla9on..?

Who Gets Atrial Fibrilla9on..? Birmingham October 20 th 2013 AFA Pa9ents Day Symptoma9c Atrial Fibrilla9on What therapies are available? GENERAL BACKGROUND Andrew Grace Papworth Hospital and University of Cambridge Consultant: Medtronic

More information

Therapeutic Targets and Interventions

Therapeutic Targets and Interventions Therapeutic Targets and Interventions Ali Valika, MD, FACC Advanced Heart Failure and Pulmonary Hypertension Advocate Medical Group Midwest Heart Foundation Disclosures: 1. Novartis: Speaker Honorarium

More information

Need to Know: Implantable Devices. Carolyn Brown RN, MN, CCRN Education Coordinator Emory Healthcare Atlanta, Georgia

Need to Know: Implantable Devices. Carolyn Brown RN, MN, CCRN Education Coordinator Emory Healthcare Atlanta, Georgia Need to Know: Implantable Devices Carolyn Brown RN, MN, CCRN Education Coordinator Emory Healthcare Atlanta, Georgia Disclosure Statement I have no relationships to disclose. Objectives Discuss the most

More information

ABLATION OF CHRONIC AF

ABLATION OF CHRONIC AF ABLATION OF CHRONIC AF A PISAPIA ST JOSEPH HOSPITAL MARSEILLE MEET 2008 Atrial Fibrillation The most common significant heart rhythm disturbance Incidence increases with age and the development of structural

More information

Why to monitor AF ablation success?

Why to monitor AF ablation success? Why to monitor AF ablation success? Why to monitor AF ablation success? CASTLE-AF Primary Endpoint All-cause mortality Worsening heart failure admissions Secondary Endpoints All-cause mortality Worsening

More information

Tachycardias II. Štěpán Havránek

Tachycardias II. Štěpán Havránek Tachycardias II Štěpán Havránek Summary 1) Supraventricular (supraventricular rhythms) Atrial fibrillation and flutter Atrial ectopic tachycardia / extrabeats AV nodal reentrant a AV reentrant tachycardia

More information

Atrial Fibrillation and Heart Failure

Atrial Fibrillation and Heart Failure Date Clinical Title Atrial Fibrillation and Heart Failure Raul Weiss MD, FAHA, FACC, FHRS and CCDS Director, Electrophysiology Fellowship Program Professor of Medicine The Ohio State University Wexner

More information

5/5/2010. World incidence 720, 000 new cases / year. World prevalence 5.55 million AF prevalence increasing with aging of population

5/5/2010. World incidence 720, 000 new cases / year. World prevalence 5.55 million AF prevalence increasing with aging of population Atrial Fibrillation: Guidelines through clinical cases and 2010 updates Samy Claude ELAYI Cardiac Clinical Pacing and Electrophysiology UK World incidence 720, 000 new cases / year World prevalence 5.55

More information

Prevention of Sudden Death in ARVC

Prevention of Sudden Death in ARVC ESC Munich, August 29, 2012 Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC): Prevention of Sudden Death in ARVC Thomas Wichter, MD, FESC Professor of Medicine - Cardiology Marienhospital Osnabrück

More information

Progression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro

Progression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro Progression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro Jerónimo Farré MD, Madrid, ES AF: the kingdom of wishful thinking In AF we

More information

עדכונים באלקטרופיזיולוגיה Electrophysiology Unit Soroka University Medical Center Faculty of Health Sciences Ben-Gurion University of the Negev

עדכונים באלקטרופיזיולוגיה Electrophysiology Unit Soroka University Medical Center Faculty of Health Sciences Ben-Gurion University of the Negev עדכונים באלקטרופיזיולוגיה 2014 Electrophysiology Unit Soroka University Medical Center Faculty of Health Sciences Ben-Gurion University of the Negev 1 מבנה הצגת היחידה פעילות ביחידה סקירה על הטיפול באלקטרופיזיולוגיה

More information

Atrial Fibrillation New Approaches, Techniques, and Technology

Atrial Fibrillation New Approaches, Techniques, and Technology New Cardiovascular Horizons 2015 May 28, 2015 New Orleans, Louisiana Atrial Fibrillation New Approaches, Techniques, and Technology State of the Art - - 2015 Richard Abben, M D Director, Cardiac Arrhythmia

More information

Risk Stratification of Sudden Cardiac Death

Risk Stratification of Sudden Cardiac Death Risk Stratification of Sudden Cardiac Death Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC USA Disclosures: None Sudden Cardiac Death A Major Public Health Problem > 1/2 of

More information

Management of Atrial Fibrillation in Heart Failure

Management of Atrial Fibrillation in Heart Failure Management of Atrial Fibrillation in Heart Failure Hani Sabbour MD FACC FHRS FASE Clinical Assistant Professor of Cardiology Brown University, Warren Alpert School of Medicine Rhode Island, USA Consultant

More information

Atrial Fibrillation: Guidelines through clinical cases and 2010 updates

Atrial Fibrillation: Guidelines through clinical cases and 2010 updates Atrial Fibrillation: Guidelines through clinical cases and 2010 updates Samy Claude ELAYI Cardiac Clinical Pacing and Electrophysiology World incidence 720, 000 new cases / year World prevalence 5.5 million

More information

Atrial fibrillation (AF) is a disorder seen

Atrial fibrillation (AF) is a disorder seen This Just In... An Update on Arrhythmia What do recent studies reveal about arrhythmia? In this article, the authors provide an update on atrial fibrillation and ventricular arrhythmia. Beth L. Abramson,

More information

The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia

The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia By Sandeep Joshi, MD and Jonathan S. Steinberg, MD Arrhythmia Service, Division of Cardiology

More information

Management of Syncope in Heart Failure. University of Iowa

Management of Syncope in Heart Failure. University of Iowa Management of Syncope in Heart Failure Brian Olshansky University of Iowa 1 Syncope Transient loss of consciousness, with rapid, usually complete, recovery, with or without prodrome A common, non-specific,

More information

Benign RVOT Ectopy and RV dysplasia

Benign RVOT Ectopy and RV dysplasia Heart Rhythm Congress Birmingham October 2009 How to distinguish between... Benign RVOT Ectopy and RV dysplasia in the child... Dr Graham Stuart 14yr old boy asymptomatic irregular pulse picked up by GP

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

2017 AHA/ACC/HRS Ventricular Arrhythmias and Sudden Cardiac Death Guideline. Top Ten Messages. Eleftherios M Kallergis, MD, PhD, FESC

2017 AHA/ACC/HRS Ventricular Arrhythmias and Sudden Cardiac Death Guideline. Top Ten Messages. Eleftherios M Kallergis, MD, PhD, FESC 2017 AHA/ACC/HRS Ventricular Arrhythmias and Sudden Cardiac Death Guideline Top Ten Messages Eleftherios M Kallergis, MD, PhD, FESC Cadiology Department - Heraklion University Hospital No actual or potential

More information

Arrhythmias Focused Review. Who Needs An ICD?

Arrhythmias Focused Review. Who Needs An ICD? Who Needs An ICD? Cesar Alberte, MD, Douglas P. Zipes, MD, Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IN Sudden cardiac arrest is one of the most common causes

More information

Treatment of VT of Purkinje fiber origin: ablation targets and outcome

Treatment of VT of Purkinje fiber origin: ablation targets and outcome Treatment of VT of Purkinje fiber origin: ablation targets and outcome Ch. Piorkowski University Leipzig - Heart Center - Dept. of Electrophysiology Leipzig, Germany Presenter Disclosure Information Gerhard

More information

Management of atrial fibrillation in heart failure

Management of atrial fibrillation in heart failure Nationale hartfalendag 2017 Zeist Management of atrial fibrillation in heart failure Isabelle C Van Gelder University of Groningen University Medical Center Groningen The Netherlands Disclosures Grant

More information

Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy

Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy Evan Adelstein, MD, FHRS John Gorcsan III, MD Samir Saba, MD, FHRS

More information

Device detected VT: How much VT is significant and is VT ablation the answer?

Device detected VT: How much VT is significant and is VT ablation the answer? Device detected VT: How much VT is significant and is VT ablation the answer? Dr Mark Mason Harefield Hospital Royal Brompton and Harefield NHS Foundation Trust What is VT (in this context)? What is VT?

More information

ICD Therapy. Disclaimers

ICD Therapy. Disclaimers ICD Therapy Rodney Horton, MD Texas Cardiac Arrhythmia Institute Texas Cardiovascular, PA Austin, TX Speaker s Bureau St. Jude Medical Medtronic Boston Scientific Disclaimers Clinical Advisory Panel St.

More information

Inappropriate electrical shocks: Tackling the beast

Inappropriate electrical shocks: Tackling the beast ESC Paris 2011 Inappropriate electrical shocks: Tackling the beast Gerhard Hindricks University of Leipzig Heart Center Dept. of Electrophysiology ESC Paris 2011 Inappropriate electrical shocks: Tackling

More information

Arrhythmic Complications of MI. Teferi Mitiku, MD Assistant Clinical Professor of Medicine University of California Irvine

Arrhythmic Complications of MI. Teferi Mitiku, MD Assistant Clinical Professor of Medicine University of California Irvine Arrhythmic Complications of MI Teferi Mitiku, MD Assistant Clinical Professor of Medicine University of California Irvine Objectives Brief overview -Pathophysiology of Arrhythmia ECG review of typical

More information

Advances in Cardiac Arrhythmias and Great innovations in Cardiology Turin October 2016

Advances in Cardiac Arrhythmias and Great innovations in Cardiology Turin October 2016 University of Brescia School of Medicine Division of cardiologiy Director: Prof Marco Metra, MD, FESC Advances in Cardiac Arrhythmias and Great innovations in Cardiology Turin 13-15 October 2016 Arrhythmias

More information

Thoranis Chantrarat MD

Thoranis Chantrarat MD Device Therapy in Heart Failure Thoranis Chantrarat MD 1 Scope of presentation Natural history of heart failure Primary and secondary prevention ICD and its indication CRT and its indication 2 Severity

More information

Prophylactic ablation

Prophylactic ablation Ventricular tachycardia in ischaemic heart disease. Update on electrical therapy 29 august 2010 Prophylactic ablation Pasquale Notarstefano Cardiovacular Department S. Donato Hospital, Arezzo (IT) Prophylactic

More information

REtrive. REpeat. RElearn Design by. Test-Enhanced Learning based ECG practice E-book

REtrive. REpeat. RElearn Design by. Test-Enhanced Learning based ECG practice E-book Test-Enhanced Learning Test-Enhanced Learning Test-Enhanced Learning Test-Enhanced Learning based ECG practice E-book REtrive REpeat RElearn Design by S I T T I N U N T H A N G J U I P E E R I Y A W A

More information

Drugs Controlling Myocyte Excitability and Conduction at the AV node Singh and Vaughan-Williams Classification

Drugs Controlling Myocyte Excitability and Conduction at the AV node Singh and Vaughan-Williams Classification Drugs Controlling Myocyte Excitability and Conduction at the AV node Singh and Vaughan-Williams Classification Class I Na Channel Blockers Flecainide Propafenone Class III K channel Blockers Dofetilide,

More information

Is cardioversion old hat? What is new in interventional treatment of AF symptoms?

Is cardioversion old hat? What is new in interventional treatment of AF symptoms? Is cardioversion old hat? What is new in interventional treatment of AF symptoms? Joseph de Bono Consultant Electrophysiologist University Hospitals Birmingham Atrial Fibrillation (AF) Affects 2% of the

More information

The implantable cardioverter defibrillator is not enough: Ventricular Tachycardia Catheter Ablation in Patients with Structural Heart Disease

The implantable cardioverter defibrillator is not enough: Ventricular Tachycardia Catheter Ablation in Patients with Structural Heart Disease The implantable cardioverter defibrillator is not enough: Ventricular Tachycardia Catheter Ablation in Patients with Structural Heart Disease Paolo Della Bella, MD Arrhythmia Department and Clinical Electrophysiology

More information

EHRA Accreditation Exam - Sample MCQs Cardiac Pacing and ICDs

EHRA Accreditation Exam - Sample MCQs Cardiac Pacing and ICDs EHRA Accreditation Exam - Sample MCQs Cardiac Pacing and ICDs Dear EHRA Member, Dear Colleague, As you know, the EHRA Accreditation Process is becoming increasingly recognised as an important step for

More information

4/14/15 HTEC 91. Topics for Today. Guess That Rhythm. Premature Ventricular Contractions (PVCs) Ventricular Rhythms

4/14/15 HTEC 91. Topics for Today. Guess That Rhythm. Premature Ventricular Contractions (PVCs) Ventricular Rhythms 4/14/15 Topics for Today HTEC 91 Medical Office Diagnostic Tests Week 5 Ventricular Rhythms PVCs: Premature Ventricular Contractions VT: Ventricular Tachycardia VF: Ventricular Fibrillation Asystole Study

More information

Arrhythmia 341. Ahmad Hersi Professor of Cardiology KSU

Arrhythmia 341. Ahmad Hersi Professor of Cardiology KSU Arrhythmia 341 Ahmad Hersi Professor of Cardiology KSU Objectives Epidemiology and Mechanisms of AF Evaluation of AF patients Classification of AF Treatment and Risk stratification of AF Identify other

More information

Heart Failure and Atrial Fibrillation

Heart Failure and Atrial Fibrillation Heart Failure and Atrial Fibrillation 신미승 가천의대심장내과 Prevalence of AF & CHF AF : the most common cardiac arrhythmia more than 2.2 million Americans -- 2007 ACC CHF : more than 5 million Americans The prevalence

More information

Mission Statement for our Arrhythmia Care

Mission Statement for our Arrhythmia Care Mission Statement for our Arrhythmia Care We are dedicated to provide a compassionate and an outstanding care for patients with cardiac arrhythmias. We will be utilizing the cutting edge and the most advanced

More information

Ventricular arrhythmias

Ventricular arrhythmias Ventricular arrhythmias Assoc.Prof. Lucie Riedlbauchová, MD, PhD Department of Cardiology University HospitalMotol and2nd FacultyofMedicine, Charles University in Prague Definition and classification Ventricular

More information

Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes

Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes Catheter Ablation for Atrial Fibrillation: Patient Selection and Outcomes Francis Marchlinski, MD Richard T and Angela Clark President s Distinguished Professor Director Cardiac Electrophysiolgy University

More information

Heart Rhythm Disorders. How do you quantify risk?

Heart Rhythm Disorders. How do you quantify risk? Heart Rhythm Disorders How do you quantify risk? Heart Rhythm Disorders Scale of the Problem 1/2 population will have an episode of transient loss of consciousness (T-LOC) at some stage in their life.

More information